Ribavirin
Product Images NDC 53808-0781

29 FDA label images from State Of Florida Doh Central Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 53808-0781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image For 200mg (Ribavirin 200mg(sandoz))

Label Image For 200mg (Ribavirin 200mg(sandoz))
Label for Ribavirin 200 mg capsules, quantity of 30, RX only. Packaged by DOH Central Pharmacy, Tallahassee, FL 32304. Lot numbers and expiration date are printed on the label, along with a barcode and UPC# 307812043042.*
FDA Label Image

Structural Formula (Ribavirin 01)

Structural Formula (Ribavirin 01)
Chemical structure of ribavirin, showing the molecular arrangement including a ribose sugar and a triazole base with an amide functional group.*
FDA Label Image

Figure 2 (Ribavirin 02)

Figure 2 (Ribavirin 02)
An instructional diagram showing the parts of a test strip for Ribavirin. The labeled components include the flange, latex membrane, electrode area, ribs, red strip, and protective cap.*
FDA Label Image

Figure 3 (Ribavirin 03)

Figure 3 (Ribavirin 03)
An instructional illustration showing a person performing a task involving the arm and hand, possibly related to an injection or medical procedure, with arrows indicating motion or steps to follow.*
FDA Label Image

Figure 4 (Ribavirin 04)

Figure 4 (Ribavirin 04)
An instructional illustration showing a hand drawing fluid from a vial with a syringe. The vial is labeled Ribavirin, indicating preparation or administration of the Ribavirin drug product from the State of Florida DOH Central Pharmacy.*
FDA Label Image

Figure 5 (Ribavirin 05)

Figure 5 (Ribavirin 05)
An instructional line drawing depicting a person using a nasal spray device. The illustration shows the person holding the spray and inserting the nozzle into a nostril, demonstrating the proper administration technique for a nasal spray product.*
FDA Label Image

Figure 6 (Ribavirin 06)

Figure 6 (Ribavirin 06)
Ribavirin bottle label displaying the product name Ribavirin. The label includes dosage form as capsules, presented in a white bottle with a child-resistant cap. The label shows the State of Florida Department of Health Central Pharmacy as the labeler. Product NDC 53808-0781 is printed on the label.*
FDA Label Image

Figure 7 (Ribavirin 07)

Figure 7 (Ribavirin 07)
An instructional illustration showing a hand holding a small measuring cup or oral syringe to administer liquid medication into a patient's mouth, demonstrating proper dosing technique for oral medication delivery.*
FDA Label Image

Figure 8 (Ribavirin 08)

Figure 8 (Ribavirin 08)
An illustration showing a sequence of stylized line drawings depicting human figures in various poses involving the arm and shoulder area. The images may be instructional or anatomical in nature related to movements or physical therapy exercises.*
FDA Label Image

Figure 9 (Ribavirin 09)

Figure 9 (Ribavirin 09)
An instructional line drawing showing a hand holding a syringe with a needle inserted into an upper arm muscle, demonstrating proper intramuscular injection technique.*
FDA Label Image

Figure 10 (Ribavirin 10)

Figure 10 (Ribavirin 10)
An illustration showing step-by-step how to use a finger to manipulate a small item, possibly a needle or stick. Two hands are depicted, with fingers demonstrating a twisting or pulling motion on a thin cylindrical object. No text is visible.*
FDA Label Image

Figure 11 (Ribavirin 11)

Figure 11 (Ribavirin 11)
The image shows a clear plastic syringe labeled with the proprietary name Ribavirin. The syringe has markings for dosage measurement and a plunger with a rubber stopper. The label includes the State of Florida DOH Central Pharmacy as the labeler. The syringe is designed for oral or injectable administration.*
FDA Label Image

Figure 12 (Ribavirin 12)

Figure 12 (Ribavirin 12)
An instructional illustration showing a sequence of hand movements involved in opening a medication blister pack. The images demonstrate peeling or pulling back the protective foil to access individual doses inside the packaging.*
FDA Label Image

Figure 13 (Ribavirin 13)

Figure 13 (Ribavirin 13)
An instructional diagram illustrating how to use a nasal spray device. The image shows a hand holding the spray bottle positioned at the nostril and indicates the direction for spray administration.*
FDA Label Image

Figure 14 (Ribavirin 14)

Figure 14 (Ribavirin 14)
Ribavirin vial packaging label showing the product name Ribavirin. The label includes a lot number, expiration date, and instructions for use. Manufacturer listed as State of Florida DOH Central Pharmacy with product NDC 53808-0781. The vial appears to contain a clear liquid dosage form.*
FDA Label Image

Figure 15 (Ribavirin 15)

Figure 15 (Ribavirin 15)
An instructional illustration showing the process of opening a container or vial by twisting or pulling, involving two hands. The image likely depicts a step in medication preparation or administration.*
FDA Label Image

Figure 16 (Ribavirin 16)

Figure 16 (Ribavirin 16)
An instructional illustration showing two steps of assembling or using a device. The left shows a hand holding a small container or vial, and the right shows a hand attaching or connecting a syringe or similar component to the container. The image visually guides handling or preparation.*
FDA Label Image

Figure 17 (Ribavirin 17)

Figure 17 (Ribavirin 17)
An instructional illustration showing a hand drawing blood from a fingertip using a lancet device labeled Ribavirin. The image depicts the procedure of a fingerstick blood sample collection.*
FDA Label Image

Figure 18 (Ribavirin 18)

Figure 18 (Ribavirin 18)
Chemical structure of Ribavirin, shown as a molecular diagram with labeled atoms and bonds, illustrating the chemical composition of this active ingredient.*
FDA Label Image

Figure 19 (Ribavirin 19)

Figure 19 (Ribavirin 19)
Chemical structure of Ribavirin shown as a molecular diagram with atoms and bonds represented by standard chemical notation.*
FDA Label Image

Figure 20 (Ribavirin 20)

Figure 20 (Ribavirin 20)
An anatomical instructional illustration showing a person's upper torso and head. The diagram depicts the placement of electrodes on the shoulder, chest, and torso area for a medical procedure, with a depiction of a hand holding a device near the subject's torso.*
FDA Label Image

Figure 21 (Ribavirin 21)

Figure 21 (Ribavirin 21)
An instructional diagram showing the technique of using a metered-dose inhaler (MDI). The illustration includes a person holding and using the inhaler with a spacer device, demonstrating proper inhalation method and positioning for medication delivery.*
FDA Label Image

Figure 22 (Ribavirin 22)

Figure 22 (Ribavirin 22)
An instructional illustration demonstrating the process of opening or closing a medication bottle cap. The image shows a hand gripping a ribbed bottle cap and twisting it, with an arrow indicating the direction of rotation. This diagram is likely intended to show proper handling of the bottle closure for Ribavirin medication.*
FDA Label Image

Figure 23 (Ribavirin 23)

Figure 23 (Ribavirin 23)
An instructional diagram illustrating the proper technique for using a nasal spray. It shows a person tilting their head slightly forward and inserting the spray nozzle into one nostril while closing the other nostril. The spray is being administered into the nasal passage as per typical usage guidance.*
FDA Label Image

Figure 24 (Ribavirin 24)

Figure 24 (Ribavirin 24)
An instructional line drawing showing how to use an oral dosing device, likely a syringe or dropper, for administering medication. The illustration depicts a hand holding the device and positioning it near a mouth for dosage.*
FDA Label Image

Figure 25 (Ribavirin 25)

Figure 25 (Ribavirin 25)
FDA Label Image

Figure 26 (Ribavirin 26)

Figure 26 (Ribavirin 26)
An instructional illustration showing how to open and use a Ribavirin inhalation device. It depicts a hand removing a cap from the inhaler, demonstrating the correct handling step for administration.*
FDA Label Image

Figure 27 (Ribavirin 27)

Figure 27 (Ribavirin 27)
An instructional diagram illustrating how to break or open a tablet or pill using hands. The image shows fingers holding the medication with an arrow indicating a separating or splitting action.*
FDA Label Image

Figure 28 (Ribavirin 28)

Figure 28 (Ribavirin 28)
An instructional diagram showing a hand turning a container, likely demonstrating how to open or pour from it. The image includes arrows indicating the direction of motion, suggesting steps in using the product container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.